The FDA approves the Pfizer COVID-19 vaccine in adolescents

(WAOW) – The U.S. and Drug Administration has expanded the Emergency Use (EUA) approval for the Pfizer-BioNTech .

It is now approved for teenagers between the ages of 12 and 15.

Pfizer was the first vaccine to be approved in December 2020 to fight the -19 pandemic.

Acting FDA Commissioner Janet Woodcock, MD made the following statement on enlargement.

“The FDA’s extension of emergency approval for the Pfizer-BioNTech COVID-19 vaccine to adolescents ages 12-15 is an important step in the fight against the COVID-19 pandemic,” said Acting FDA Commissioner Janet Woodcock , MD “Today’s action is making it possible to protect a younger population from COVID-19, which brings us closer to returning to a sense of normalcy and ending the pandemic. Parents and guardians can rest assured that the agency has carried out a rigorous and thorough review of all available data, as we have done with all of our COVID-19 emergency vaccine approvals. “

This is an evolving story that is being updated.

Comments are closed.